We are honoured to present the 2024 annual report from DANDRITE – the Danish Research Institute of Translational Neuroscience and the Danish node of the Nordic EMBL Partnership for Molecular Medicine.
2024 was a year where DANDRITE reaffirmed its position as a key player in Danish neuroscience by maintaining our core mission of advancing brain research—from molecular mechanisms to complex circuits—with impactful scientific output and growing recognition. Key developments include:
Scientific Achievements: Researchers received prestigious national and international grants and published high-impact papers on synaptic function and neuroimmune communication.
Leadership Changes: Three founding group leaders completed their terms, and two new leaders, Anna Mathia Klawonn and Fiona Müllner, joined, enhancing expertise in immune-brain signaling and visual perception circuits.
SAB Evaluation: The Scientific Advisory Board affirmed DANDRITE’s strategic progress and applauded both the innovation of new leaders and the excellence of junior researchers.
Partnership Growth: New collaborations were initiated, including the NORPOD postdoctoral programme and revitalization of the Affiliated Researcher programme with Aarhus University.
Diversity and Inclusion: DANDRITE signed the ALBA Declaration and launched initiatives like the Newcomer’s Club to support integration and equity.
Looking Ahead: As 2025 begins, DANDRITE strengthens its physical presence and collaboration at Aarhus University with new facilities and renewed research momentum.
We hope you will enjoy reading, exploring, and learning about our highlights from 2024 and seeing how we're evolving as a community and as a high level research center.
- Interim Director Poul Henning Jensen
